Skip to main content
lexblog.com/lib/CQBSFEJNviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Putative class counsel in generic drug antitrust MDL can’t get a slice of the opt-out pie . . . At least not yet",
    "url": "https://www.lexblog.com/2019/10/21/putative-class-counsel-in-generic-drug-antitrust-mdl-cant-get-a-slice-of-the-opt-out-pie-at-least-not-yet/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-CQBSFEJN",
        "url": "https://www.lexblog.com/lib/CQBSFEJN/"
    },
    "datePublished": "2019-10-21T15:46:10-04:00",
    "dateModified": "2022-10-03T05:19:23-04:00",
    "author": {
        "@type": "Person",
        "name": "Porter Wright"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Porter Wright Morris & Arthur LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Antitrust Law Source",
    "about": "Antitrust, Competition and Trade · Class Action & Mass Torts",
    "sourceUrl": "https://www.antitrustlawsource.com/?p=1597",
    "sourceStability": "may-move"
}